Tag: Therapeutics
Timberlyne Therapeutics Raises $180M in Series A Funding
Timberlyne Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical firm targeted on the event of recent therapies for autoimmune…
Light Horse Therapeutics Raises $62M in Series A Financing
Light Horse Therapeutics, a San Diego, CA-based developer of small molecule therapeutics, raised $62M in Sequence A funding.…
Neumirna Therapeutics Raises €20M in Series A Funding
Neumirna Therapeutics, a Copenhagen, Denmark-based RNA-focused biotech firm, raised €20M in Collection A funding. The spherical was led…
Tenvie Therapeutics Raises $200M in Funding
Tenvie Therapeutics, a San Francisco, CA-based biotechnology firm dedicated to engineering small molecules for the therapy of neurological…
Alesta Therapeutics Raises €65M in Series A Funding
Alesta Therapeutics, a Leiden, the Netherlands-based biotechnology firm targeted on growing transformative small molecule therapies for uncommon ailments,…
Aviceda Therapeutics Raises Upsized $207.5M in Series C Financing
Aviceda Therapeutics, a Cambridge, MA-based non-public, clinical-stage biotech firm centered on growing new immunomodulators, raised $207.5M in Collection…
HERVolution Therapeutics Raises $11.7M in Series A Funding
HERVolution Therapeutics, a Copenhagen, Denmark-based darkish genome-focused biotechnology firm, raised $11.7M in Sequence A funding. The spherical was…
Alessa Therapeutics Closes $15M Seed Financing
Alessa Therapeutics, a San Carlos, CA-based clinical-stage drug growth firm, raised $15M in Seed funding. The spherical was…
Secretome Therapeutics Raises $20.4M in Financing
Secretome Therapeutics, a Dallas, TX-based biotechnology firm advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), raised $20.4M…
Pep2Tango Therapeutics Receives Investment from Versant Ventures
Pep2Tango Therapeutics, a Potomac, MD-based startup centered on weight reduction therapies, obtained an funding from Versant Ventures. The…
Blue Earth Therapeutics Closes $76.5M Series A Financing
Blue Earth Therapeutics Ltd, an Oxford, UK-based chief within the growth of therapeutic radiopharmaceuticals, closed a $76.5M Collection A financing. The…
AbbVie to Acquire Aliada Therapeutics
AbbVie (NYSE: ABBV), Chicago, IL-based acquired Aliada Therapeutics, a Boston, MA-based biotechnology firm targeted on central nervous system (CNS) illnesses.…